Last Updated:June 19, 2025, 17:25 IST
The GMP of the Influx Healthtech IPO is 39.58%, indicating strong listing gains for investors.
The Influx Healthtech IPO received a 5.89 times subscription on Day 1 on Wednesday.
Influx Healthtech IPO Day 2: The initial public offering of Influx Healthtech Ltd witnessed the second day of bidding on Thursday, June 19. The IPO has received a decent response from investors. Till 5:20 pm on the second day of bidding on Thursday, the Rs 55.63-crore SME IPO received a 25.33 times subscription, garnering bids for 10,27,87,200 shares as against 40,58,400 shares on offer.
The retail and NII participation stood at 35.86 times and 32.25 times, respectively. Its qualified institutional buyer (QIB) category got a 1.69 times subscription.
Also Read: Oswal Pumps IPO Listing Tomorrow: Here’s What Latest GMP Signals
The three-day IPO was opened on Wednesday, June 18, and will be closed on Friday, June 20. It received a 5.89 times subscription on Day 1 on Wednesday.
Influx Healthtech IPO Price
The price of the Influx Healthtech IPO has been fixed at Rs 96 apiece.
Influx Healthtech IPO Lot Size
The minimum lot size is 1,200 shares, requiring a retail investment of Rs 1,15,200. For NIIs, the minimum is 2 lots (2,400 shares) at Rs 2,30,400.
Influx Healthtech IPO GMP Today
According to market observers, the GMP of the Influx Healthtech IPO is 39.58%, indicating strong listing gains for investors.
The shares of Influx Healthtech Ltd will be listed on the NSE SME on June 25.
The GMP is based on market sentiments and keeps changing. ‘Grey market premium’ indicates investors’ readiness to pay more than the issue price.
Influx Healthtech IPO: More Info
The Eppeltone Engineers IPO is a book-built issue worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh equity shares worth Rs 45.07 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore.
The IPO opened for subscription on June 18, 2025, and will close on June 20, 2025. Share allotment is likely to be finalised on June 23, with the listing expected on the NSE SME platform on June 25, 2025.
The price band is set at Rs 96 per share.
Influx Healthtech Ltd’s revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024.
Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited.
Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to markets, economy and companies. Having a decade of experience in financial journalism, Haris has been previously asso…Read More
Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to markets, economy and companies. Having a decade of experience in financial journalism, Haris has been previously asso… Read More
- First Published:
#Influx #Healthtech #IPO #Receives #25.3x #Subscription #Day #Check #GMP #Today #Ipo #News
